Yep, I would strongly advise against any punters who are expecting a $7B valuation prior to any approvals.
After approval, various speculative price targets are possible as a self funded company can get start being valued for its other indications, which have multiples of revenue potential over the pediatric Sr aGVHD.
Ann: Change in substantial holding, page-204
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.023(1.95%) |
Mkt cap ! $1.341B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.19 | $1.15 | $2.864M | 2.448M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 88975 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 78178 | 13 |
View Market Depth
| Last trade - 13.05pm 23/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |